Skip to main content
logo
Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.55
+1.27 (13.69%)
At close: Aug 14, 2026, 4:00 PM EDT
10.45
-0.11 (-1.00%)
After-hours: Aug 14, 2026, 4:24 PM EDT

Sagimet Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-47.08-51.04-45.57-27.88-30.5-24.44
Loss (Gain) From Sale of Investments
0.22-0.39-1.25-0.04-0.21-
Stock-Based Compensation
8.916.455.294.991.881.9
Other Operating Activities
0.380.380.150.140.130.88
Change in Accounts Payable
-2.010.93-0.910.122.920.56
Change in Other Net Operating Assets
-2.14-1.98-0.14-1.11.3-0.62
Operating Cash Flow
-41.72-45.65-42.44-23.77-24.49-21.71
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Investment in Securities
0.634.56-61.6812.58-32.01-
Investing Cash Flow
0.634.56-61.6812.58-32.01-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
175.460.28105.8689.690.010.19
Other Financing Activities
-10.8--1.05-3.52-0.09-1.25
Financing Cash Flow
164.660.28104.8286.17-0.079.74

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
123.57-40.820.774.98-56.57-11.97

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
-27.82-30.22-29.73-15.08-13.21-14.27
Unlevered Free Cash Flow
-27.82-30.22-29.73-15.08-13.21-14.27

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-4.15-1.05-1.05-0.984.21-0.06
SEC Filings: 10-K · 10-Q